Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Empirical vs Enhanced Antibiotic Prophylaxis for UTI Prevention After Flexible Ureteroscopy in Children
NCT07229755Phase 3Completed
- Sponsor
- Ain Shams University
- Start
- Jul 2024
- Primary completion
- Dec 2024
- Modality
- Reversible Covalent Inhibitors
- Countries
- 1
01
Overview
Phase 3, randomised trial of ceftriaxone and levofloxacin in urinary tract infection (UTI) (2 arms), sponsored by Ain Shams University. Primary endpoint: Rate of Urinary Tract Infection at 2 weeks. Started Jul 2024; status: completed.
02
Drugs
ceftriaxonelevofloxacin
03
Conditions
urinary tract infection (UTI)
Beyond the preview
Go deeper on NCT07229755.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07229755.